메뉴 건너뛰기




Volumn 2, Issue 4, 2016, Pages

Looking to the future of organ-on-chip and toxicity assessment: A regulator's opinion

Author keywords

organ on chip; pharmacology; regulation; toxicology

Indexed keywords

CARCINOGENICITY; EUROPE; MEDICAL TECHNOLOGY; MEDICOLEGAL ASPECT; ORGAN ON CHIP TECHNOLOGY; PRECLINICAL STUDY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TOXICITY ASSAY;

EID: 85063607609     PISSN: None     EISSN: 20565623     Source Type: Journal    
DOI: 10.4155/fsoa-2016-0068     Document Type: Review
Times cited : (5)

References (6)
  • 3
    • 84961620659 scopus 로고    scopus 로고
    • Waiving in vivo studies for monoclonal antibody biosimilar development: National and global challenges
    • Chapman K, Adjei A, Baldrick P et al. Waiving in vivo studies for monoclonal antibody biosimilar development: national and global challenges. MAbs 8(3), 427-435 (2016).
    • (2016) MAbs , vol.8 , Issue.3 , pp. 427-435
    • Chapman, K.1    Adjei, A.2    Baldrick, P.3
  • 4
    • 84991264839 scopus 로고    scopus 로고
    • Organs-on-chips' go mainstream
    • Reardon S. 'Organs-on-chips' go mainstream. Nature 523(7560), 266 (2015).
    • (2015) Nature , vol.523 , Issue.7560 , pp. 266
    • Reardon, S.1
  • 6
    • 85069006303 scopus 로고    scopus 로고
    • ILSI Health and Environmental Sciences Institute. www.hesiglobal.org


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.